C
Charmacy Pharmaceutical Co Ltd
HKEX:2289
Charmacy Pharmaceutical Co Ltd
HKEX:2289
Price:
14 HKD
Market Closed
Updated:
May 21, 2024
Charmacy Pharmaceutical Co Ltd
Net Income (Common)
|
Charmacy Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison
Comparables:
1099
601607
600998
C
600511
000963
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Charmacy Pharmaceutical Co Ltd
HKEX:2289
|
Net Income (Common)
¥51.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Net Income (Common)
¥9.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
15%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Net Income (Common)
¥3.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Net Income (Common)
¥2.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
16%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Net Income (Common)
¥2.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
9%
|
CAGR 10-Years
18%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Net Income (Common)
¥2.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
17%
|
See Also
What is Charmacy Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
51.3m
CNY
51.3m
CNY
Based on the financial report for Dec 31, 2023, Charmacy Pharmaceutical Co Ltd's Net Income (Common) amounts to 51.3m CNY.
What is Charmacy Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
2%
2%
Over the last year, the Net Income (Common) growth was -43%. The average annual Net Income (Common) growth rates for Charmacy Pharmaceutical Co Ltd have been 8% over the past three years , 2% over the past five years .
You don't have any saved screeners yet
